Recent Overview on the Molecular Hybrids Integrated With Benzosuberone/Benzo[7]annulene Derivatives as Multi‐Target Therapeutics
Archiv der Pharmazie · 2026-07 · 359 (7)
DOI: 10.1002/ardp.70300 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, online erschienen am 15.07.2026. Verfasst von Mohamed S Nafie und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Sciences, University of Sharjah, Sharjah, UAE. Hauptthemen laut MEDLINE: Antineoplastic Agents, Coumarins, Neoplasms. Die Arbeit nennt 112 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Benzosuberone is a promising scaffold with a remarkably varied pharmacological profile that has been attracting significant interest in the potential development of anticancer agents. This review focuses on the historical interest, diversity of chemical structures, and different medicinal applications of benzosuberone derivatives, particularly as agents with potential anticancer activity. We investigated the relationship between structure modification and biological activity by focusing on the molecular hybrids of the present hit with various functionalities or heterocycles, which led to improved cytotoxicity against several cancer cell lines, and miscellaneous biological activities such as antimicrobial, antiviral, neurological, antiparasitic, anti‐diabetic, and antitubercular activities. Detailed in vitro analyses showed promising cytotoxicity against breast, lung, and colon cancers, presenting IC 50 values in the low micromolar and submicromolar ranges and low toxicity profiles concerning normal cells. Novel approaches, including the hybrid molecule, combinatory therapy, and nano‐formulation, are suggested to go beyond the current obstacles and expand the applications of benzosuberone‐based derivatives toward clinical applications. This combined study demonstrates that the benzosuberone scaffold is a privileged structure in the search for miscellaneous biological drugs with high therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, College of Sciences, University of Sharjah, Sharjah, UAE.
- Bioinformatics and Functional Genomics Research Group, Research Institute of Sciences and Engineering (RISE), University of Sharjah, Sharjah, UAE.
- Department of Chemistry, Faculty of Science, Suez Canal University, Ismailia, Egypt.
- Department of Chemistry, Faculty of Science, Cairo University, Giza, Egypt.
- Pest Physiology Department, Agricultural Research Center, Plant Protection Research Institute, Giza, Egypt.
ORCID-Profile: Mohamed S Nafie, Kamal M Dawood, Mohamed K Diab, Ashraf A Abbas
Zitieren
APA
Nafie, M. S., Dawood, K. M., Diab, M. K., & Abbas, A. A. (2026). Recent Overview on the Molecular Hybrids Integrated With Benzosuberone/Benzo[7]annulene Derivatives as Multi‐Target Therapeutics. Archiv der Pharmazie, 359(7). https://doi.org/10.1002/ardp.70300
Vancouver
Nafie MS, Dawood KM, Diab MK, Abbas AA. Recent Overview on the Molecular Hybrids Integrated With Benzosuberone/Benzo[7]annulene Derivatives as Multi‐Target Therapeutics. Archiv der Pharmazie. 2026;359(7). doi:10.1002/ardp.70300
BibTeX
@article{Nafie2026,
author = {Nafie, Mohamed S and Dawood, Kamal M and Diab, Mohamed K and Abbas, Ashraf A},
title = {Recent Overview on the Molecular Hybrids Integrated With Benzosuberone/Benzo[7]annulene Derivatives as Multi‐Target Therapeutics},
journal = {Archiv der Pharmazie},
year = {2026},
volume = {359},
number = {7},
doi = {10.1002/ardp.70300}
}
EUVIMED